A O +
third O +
MAR O +
is O +
located O +
at O +
8q24 O +
. O +
12 O +
- O +
q24 O +
. O +
21 O +
and O +
is O +
common O +
to O +
MCF B-CellLine +
- I-CellLine +
7 I-CellLine +
, O +
ZR B-CellLine +
- I-CellLine +
75 I-CellLine +
- I-CellLine +
30 I-CellLine +
and O +
SK B-CellLine +
- I-CellLine +
BR I-CellLine +
- I-CellLine +
3 I-CellLine +
, O +
whereas O +
lower O +
- O +
level O +
gains O +
are O +
apparent O +
in O +
BT B-CellLine +
- I-CellLine +
474 I-CellLine +
, O +
UACC B-CellLine +
- I-CellLine +
893 I-CellLine +
and O +
MDA B-CellLine +
- I-CellLine +
MB I-CellLine +
- I-CellLine +
231 I-CellLine +
. O +

Mutation O +
M96V O +
prevents O +
CX2 O +
( O +
filter O +
remains O +
in O +
NX O +
) O +
even O +
at O +
high O +
[ O +
K O +
+ O +
] O +
( O +
Figure O +
3B O +
) O +
. O +

GenBank O +
accession O +
numbers O +
for O +
the O +
genomic O +
sequences O +
of O +
the O +
H5N1 O +
viruses O +
isolated O +
from O +
subjects O +
CL26 O +
( O +
A O +
/ O +
Vietnam O +
/ O +
CL26 O +
/ O +
2004 O +
) O +
, O +
CL36 O +
( O +
A O +
/ O +
Vietnam O +
/ O +
CL36 O +
/ O +
2004 O +
) O +
and O +
CL115 O +
( O +
A O +
/ O +
Vietnam O +
/ O +
CL115 O +
/ O +
2005 O +
) O +
, O +
have O +
been O +
published O +
previously O +
[ O +
3 O +
] O +
. O +

Compared O +
to O +
monolayer O +
cells O +
, O +
the O +
adhesion O +
of O +
day O +
2 O +
IOSE29 B-CellLine +
spheroids O +
decreased O +
by O +
approximately O +
50 O +
% O +
or O +
more O +
( O +
p O +
< O +
0 O +
. O +
05 O +
) O +
, O +
while O +
adhesion O +
of O +
OVHS1 B-CellLine +
and O +
HEY B-CellLine +
remained O +
unchanged O +
with O +
no O +
significant O +
differences O +
on O +
any O +
of O +
the O +
ECM O +
components O +
( O +
Figure O +
3 O +
) O +
. O +

Interestingly O +
, O +
we O +
found O +
that O +
MRE11 O +
protein O +
had O +
a O +
markedly O +
faster O +
mobility O +
in O +
NBS1 O +
GM15808 B-CellLine +
cells O +
relative O +
to O +
all O +
other O +
cell O +
types O +
analyzed O +
, O +
including O +
NBS1 O +
GM07078 B-CellLine +
( O +
Fig O +
. O +
3C O +
) O +
. O +

Consistent O +
with O +
the O +
observations O +
described O +
above O +
, O +
blocking O +
CXCL1 O +
by O +
adding O +
a O +
neutralizing O +
antibody O +
also O +
completely O +
inhibited O +
Py B-CellLine +
- I-CellLine +
4 I-CellLine +
- I-CellLine +
1 I-CellLine +
endothelial O +
tube O +
formation O +
induced O +
by O +
treatment O +
with O +
conditioned O +
media O +
from O +
LS B-CellLine +
- I-CellLine +
174 I-CellLine -
T I-CellLine +
( O +
Fig O +
. O +
6 O +
E O +
) O +
or O +
HCA B-CellLine +
- I-CellLine +
7 I-CellLine +
( O +
Fig O +
. O +
6 O +
F O +
) O +
cells O +
. O +

Moreover O +
, O +
the O +
invasive O +
phenotype O +
of O +
the O +
U87MG B-CellLine +
and O +
U373MG B-CellLine +
glioblastoma O +
cell O +
lines O +
was O +
clearly O +
dependent O +
on O +
N O +
- O +
cadherin O +
activity O +
, O +
because O +
it O +
was O +
inhibited O +
after O +
application O +
of O +
the O +
N O +
- O +
cadherin O +
blocking O +
antibody O +
GC O +
- O +
4 O +
( O +
Fig O +
. O +
5 O +
C O +
) O +
, O +
whereas O +
it O +
was O +
noneffective O +
on O +
FM B-CellLine +
- I-CellLine +
45 I-CellLine +
cells O +
that O +
express O +
mainly O +
cadherin O +
- O +
11 O +
( O +
Fig O +
. O +
5 O +
A O +
, O +
and O +
unpublished O +
data O +
) O +
. O +

Transduction O +
of O +
melanocytes O +
and O +
SK23 B-CellLine +
- I-CellLine +
MEL I-CellLine +
was O +
performed O +
by O +
cultivation O +
with O +
retrovirus O +
- O +
containing O +
supernatant O +
in O +
the O +
presence O +
of O +
polybrene O +
( O +
0 O +
. O +
8 O +
mg O +
/ O +
ml O +
) O +
. O +

59 O -
M O +
fT3N0M1 O +
1680 O +
73 O +
Femur O +
prosthesis O +
+ O +
+ O +
- O +
- O +
MRI O +
pelvis O +
/ O +
femur O +
: O +
reactive O +
tissue O +
around O +
the O +
femur O +
prosthesis O +
; O +
FDG O +
PET O +
: O +
lesions O +
in O +
costae O +
and O +
pelvis O +
1 O +

The O +
COX O +
and O +
QBL O +
haplotype O +
are O +
monomodular O +
for O +
RCCX O +
, O +
whereas O +
the O +
PGF O +
, O +
SSTO O +
and O +
DBB O +
haplotypes O +
are O +
bimodular O +
. O +

Still O +
it O +
is O +
a O +
major O +
obstacle O +
that O +
hCoV O +
- O +
NL63 O +
replicates O +
slowly O +
and O +
at O +
relatively O +
low O +
titres O +
in O +
all O +
current O +
cell O +
cultures O +
, O +
such O +
as O +
LLC B-CellLine +
- I-CellLine +
MK2 I-CellLine +
and O +
Vero B-CellLine +
- I-CellLine +
B4 I-CellLine +
cells O +
[ O +
4 O +
, O +
28 O +
, O +
29 O +
] O +
. O +

CRABP1 O +
transfection O +
of O +
AMC B-CellLine +
- I-CellLine +
HN I-CellLine +
- I-CellLine +
7 I-CellLine +
cells O +
results O +
in O +
an O +
increased O +
CYP26 O +
- O +
mediated O +
catabolism O +
of O +
RA O +
[ O +
27 O +
] O +
. O +

After O +
ligasing O +
a O +
synthesized O +
RGM249 O +
( O +
Operon O +
Biotechnologies O +
, O +
Tokyo O +
, O +
Japan O +
) O +
into O +
the O +
pRNAT O +
/ O +
U6 O +
. O +
1 O +
/ O +
Neo O +
/ O +
GFP O +
vector O +
( O +
GeneScript O +
Corp O +
. O +
, O +
Piscataway O +
, O +
NJ O +
, O +
USA O +
) O +
digested O +
at O +
the O +
KpnI O +
/ O +
SacI O +
site O +
, O +
it O +
was O +
transfected O +
into O +
several O +
cell O +
lines O +
( O +
A172 B-CellLine +
, O +
T98 B-CellLine -
G I-CellLine +
, O +
HLF B-CellLine +
, O +
HT1080 B-CellLine +
, O +
HeLa B-CellLine +
, O +
SW480 B-CellLine +
, O +
Huh7 B-CellLine +
, O +
HepG2 B-CellLine +
, O +
HMc B-CellLine +
- I-CellLine +
Li7 I-CellLine +
, O +
KMST B-CellLine +
- I-CellLine +
6 I-CellLine +
, O +
SUSM B-CellLine +
- I-CellLine +
1 I-CellLine +
, O +
and O +
NIH3T3 B-CellLine +
) O +
, O +
with O +
NH B-CellLine +
- I-CellLine +
12 I-CellLine +
as O +
senescence O +
- O +
programmed O +
cell O +
lines O +
, O +
and O +
keratinocytes O +
and O +
TIG B-CellLine +
1 I-CellLine +
- I-CellLine +
20 I-CellLine +
as O +
primary O +
cells O +
. O +

Lysates O +
were O +
centrifuged O +
at O +
16 O +
, O +
000 O +
x O +
g O +
for O +
10 O +
minutes O +
at O +
4degreesC O +
and O +
the O +
supernatants O +
were O +
collected O +
; O +
protein O +
concentrations O +
were O +
determined O +
using O +
the O +
bicinconinic O +
acid O +
protein O +
assay O +
( O +
Pierce O +
) O +
. O +

For O +
the O +
illustration O +
of O +
the O +
BREM O +
method O +
we O +
therefore O +
use O +
the O +
threshold O +
of O +
> O +
= O +
2 O +
as O +
test O +
positive O +
. O +

Pictures O +
of O +
crystal O +
violet O +
- O +
stained O +
cells O +
are O +
of O +
KKU B-CellLine +
- I-CellLine +
M213 I-CellLine +
CCA O +
cells O +
in O +
comparison O +
between O +
with O +
and O +
without O +
PN O +
. O +

The O +
human O +
cell O +
lines O +
ALL B-CellLine +
- I-CellLine +
SIL I-CellLine +
( O +
T O +
- O +
cell O +
leukemia O +
) O +
and O +
RPM1 B-CellLine +
( O +
T O +
- O +
ALL O +
) O +
were O +
cultured O +
in O +
RPMI O +
plus O +
10 O +
% O +
FCS O +
, O +
1 O +
% O +
sodium O +
pyruvate O +
, O +
1 O +
% O +
glutamine O +
and O +
pen O +
/ O +
strep O +
. O +

Consistent O +
with O +
published O +
data O +
( O +
Sala O +
et O +
al O +
. O +
, O +
2008 O +
; O +
Tsai O +
et O +
al O +
. O +
, O +
2008 O +
) O +
, O +
PLX4032 O +
abolished O +
the O +
ERK1 O +
/ O +
2 O +
activating O +
phosphorylation O +
in O +
BRAFV600E O +
/ O +
K O +
melanoma O +
cells O +
( O +
Figure O +
2 O +
, O +
pERK O +
, O +
YULAC B-CellLine +
, O +
YURIF B-CellLine +
, O +
YUMAC B-CellLine +
and O +
YUGEN8 B-CellLine +
) O +
. O +

For O +
the O +
FH O +
questions O +
, O +
FH22 O +
also O +
still O +
yielded O +
higher O +
TTO O +
values O +
than O +
FH10 O +
, O +
both O +
when O +
excluding O +
proportional O +
heuristic O +
subjects O +
and O +
when O +
excluding O +
subjects O +
who O +
gave O +
the O +
same O +
answer O +
to O +
both O +
questions O +
( O +
p O +
< O +
0 O +
. O +
01 O +
. O +
For O +
the O +
BP O +
questions O +
, O +
there O +
were O +
no O +
subjects O +
giving O +
the O +
same O +
answers O +
to O +
both O +
questions O +
) O +
. O +

This O +
correlates O +
with O +
baseline O +
pAkt O +
detectable O +
in O +
M233 B-CellLine +
but O +
not O +
M229 B-CellLine +
, O +
as O +
well O +
as O +
increase O +
in O +
pAkt O +
upon O +
PLX4032 O +
- O +
exposure O +
in O +
the O +
resistant O +
M233 B-CellLine +
but O +
not O +
in O +
the O +
sensitive O +
M229 B-CellLine +
cell O +
line O +
. O +

Breast O +
MCF B-CellLine +
- I-CellLine +
7 I-CellLine +
+ O +
PM1 B-CellLine +
+ O +
+ O +
SK B-CellLine +
- I-CellLine +
BR I-CellLine +
- I-CellLine +
3 I-CellLine +
+ O +
+ O +
MA11 B-CellLine +
+ O +
+ O +
+ O +
BT B-CellLine +
- I-CellLine +
474 I-CellLine +
+ O +
+ O +
+ O +
MDA B-CellLine +
- I-CellLine +
MB I-CellLine +
- I-CellLine +
231 I-CellLine +
> O +
+ O +
+ O +
+ O +
T B-CellLine +
- I-CellLine +
47D I-CellLine +
> O +
+ O +
+ O +
+ O +
Colon O +
HT B-CellLine +
- I-CellLine +
29 I-CellLine +
+ O +
+ O +
HCT B-CellLine +
116 I-CellLine +
+ O +
+ O +
+ O +
Skin O +
FEMX B-CellLine +
- O +
SK B-CellLine +
- I-CellLine +
MEL I-CellLine +
- I-CellLine +
28 I-CellLine +
+ O +
Lung O +
BUX B-CellLine +
- O +
HTB B-CellLine +
- I-CellLine +
182 I-CellLine +
+ O +
+ O +
EKVX B-CellLine +
> O +
+ O +
+ O +
+ O +
SW900 B-CellLine +
> O +
+ O +
+ O +
+ O +
H146 B-CellLine +
> O +
+ O +
+ O +
+ O +
Bone O +
OHS B-CellLine +
- O +
OSA B-CellLine +
> O +
+ O +
+ O +
+ O +
Cervix O +
HeLa B-CellLine +
- O +
Ovary O +
SKOV B-CellLine +
- I-CellLine +
3 I-CellLine +
+ O +
OVCAR B-CellLine +
- I-CellLine +
3 I-CellLine +
+ O +
+ O +
Prostate O +
PC B-CellLine +
- I-CellLine +
MMI I-CellLine +
+ O +
LNCaP B-CellLine +
+ O +
+ O +
DU145 B-CellLine +
+ O +
+ O +
Brain O +
SF B-CellLine +
- I-CellLine +
295 I-CellLine +
+ O +
+ O +
D54MG B-CellLine +
+ O +
+ O +
U B-CellLine +
- I-CellLine +
138MG I-CellLine +
+ O +
+ O +
+ O +
Normal O +
tissue O +
Cell O +
line O +
scFv O +
173 O +
Fibroblast O +
LL B-CellLine +
86 I-CellLine +
> O +
+ O +
+ O +
+ O +
Bone O +
marrow O +
NBM B-CellLine +
I I-CellLine +
- O +
NBM B-CellLine +
II I-CellLine +
- O +
NBM B-CellLine +
III I-CellLine +
- O +

Conjugation O +
experiments O +
and O +
plasmid O +
analysis O +
demonstrated O +
the O +
prevalence O +
of O +
conjugative O +
resistance O +
plasmids O +
TP17 O +
and O +
TP19 O +
among O +
E O +
. O +
coli O +
isolates O +
. O +

x O +
= O +
0 O +
. O +
826 O +
6994 O +
measured O +
reflections O +
2708 O +
independent O +
reflections O +
2170 O +
reflections O +
with O +
I O +
> O +
2sigma O +
( O +
I O +
) O +
R O +
int O +
= O +
0 O +
. O +
034 O +
Bruker O +
SMART O +
CCD O +
area O +
- O +
detector O +
diffractometer O +
Absorpt O +

xtracts O +
prepared O +
from O +
XP30RO B-CellLine +
cells O +
which O +
lack O +
Poleta O +
are O +
largely O +
defective O +
in O +
TLS O +
past O +
either O +
AAF O +
or O +
CPD O +
lesions O +
, O +
indicating O +
that O +
Poleta O +
is O +
involved O +
in O +
the O +
bypass O +
of O +
both O +
lesions O +
. O +

Illumina O +
HumanHap300 O +
data O +
for O +
the O +
promyelocytic O +
leukemia O +
cancer O +
cell O +
HL B-CellLine +
- I-CellLine +
60 I-CellLine +
and O +
colon O +
cancer O +
cell O +
line O +
HT B-CellLine +
- I-CellLine +
29 I-CellLine +
were O +
obtained O +
from O +
Illumina O +
, O +
and O +
Human O +
- O +
610 O +
Quad O +
SNP O +
genotyping O +
data O +
for O +
the O +
colon O +
cancer O +
cell O +
lines O +
SW403 B-CellLine +
, O +
SW480 B-CellLine +
, O +
SW620 B-CellLine +
, O +
SW837 B-CellLine +
, O +
SW1417 B-CellLine +
and O +
LIM1863 B-CellLine +
were O +
generated O +
at O +
the O +
Ludwig O +
Institute O +
of O +
Cancer O +
Research O +
using O +
standard O +
processing O +
protocols O +
. O +

a O +
distorted O +
CuO2N4 O +
octa O +
- O +
hedral O +
geometry O +
. O +
Each O +
anion O +
acts O +
as O +
a O +
bridge O +
between O +
two O +
cations O +
, O +
thus O +
forming O +
a O +
two O +
- O +
dimensional O +
polymeric O +
network O +
parallel O +
to O +
the O +
ab O +
plane O +
. O +
The O +
packing O +
is O +
consolidated O +
by O +
O O +
- O +
H O +
. O +
. O +
. O +
O O +
hydrogen O +
bonds O +
. O +
One O +
of O +
the O +
O O +
atoms O +
of O +
the O +
ligand O +
and O +
both O +
water O +
mol O +
- O +
ecules O +
are O +
disordered O +
. O +
Related O +
literature O +
For O +
a O +

Finally O +
, O +
neither O +
P41 O +
/ O +
45 O +
- O +
nor O +
P33 O +
/ O +
37 O +
/ O +
41 O +
- O +
beta O +
- O +
catenin O +
antibodies O +
detect O +
beta O +
- O +
catenin O +
in O +
interphase O +
LIM2551 B-CellLine +
colon O +
cancer O +
cells O +
that O +
harbour O +
a O +
mutation O +
resulting O +
in O +
deletion O +
of O +
the O +
epitope O +
for O +
the O +
phospho O +
- O +
beta O +
- O +
catenin O +
antibodies O +
( O +
beta O +
- O +
catenin O +
residues O +
5 O +
- O +
72 O +
[ O +
30 O +
] O +
) O +
( O +
Fig O +
. O +
S4A O +
and O +
Fig O +
. O +
S5 O +
) O +
. O +

96 O +
- O +
well O +
plates O +
were O +
coated O +
overnight O +
with O +
0 O +
. O +
3 O +
microg O +
per O +
well O +
of O +
purified O +
monoclonal O +
antibody O +
R187 O +
( O +
kindly O +
provided O +
by O +
N O +
. O +
Fischer O +
, O +
Hamburg O +
, O +
Germany O +
) O +
. O +

In O +
this O +
study O +
, O +
we O +
found O +
that O +
perifosine O +
increased O +
the O +
expression O +
of O +
DR4 O +
and O +
DR5 O +
in O +
both O +
M4e B-CellLine +
and O +
22A B-CellLine +
cells O +
, O +
but O +
not O +
in O +
1483 B-CellLine +
cells O +
, O +
suggesting O +
the O +
possible O +
involvement O +
of O +
the O +
upregulation O +
of O +
these O +
proteins O +
in O +
perifosine O +
- O +
mediated O +
augmentation O +
of O +
TRAIL O +
- O +
induced O +
apoptosis O +
because O +
both O +
proteins O +
are O +
receptors O +
for O +
TRAIL O +
. O +

Genes O +
deregulated O +
in O +
SUDHL7 B-CellLine +
cells O +
by O +
anti O +
- O +
BCR O +
and O +
anti O +
- O +
CD20 O +
treatment O +
. O +

Fluorescence O +
lifetime O +
images O +
of O +
mouse O +
pituitary O +
GHFT1 B-CellLine +
cells O +
expressing O +
mCerulean O +
( O +
left O +
panel O +
) O +
, O +
mCerulean3 O +
( O +
right O +
panel O +
) O +
. O +

293ET B-CellLine +
cells O +
were O +
co O +
- O +
transfected O +
with O +
a O +
FLAG O +
- O +
tagged O +
construct O +
and O +
a O +
Renilla O +
Luciferase O +
- O +
tagged O +
construct O +
. O +

Human O +
pancreatic O +
cancer O +
cell O +
lines O +
, O +
PANC B-CellLine +
- I-CellLine +
1 I-CellLine +
, O +
AsPC B-CellLine +
- I-CellLine +
1 I-CellLine +
, O +
BxPC B-CellLine +
- I-CellLine +
3 I-CellLine +
, O +
CaPan B-CellLine +
- I-CellLine +
2 I-CellLine +
and O +
SW1990 B-CellLine +
, O +
were O +
purchased O +
from O +
Chinese O +
Academy O +
of O +
Sciences O +
Committee O +
Type O +
Culture O +
Collection O +
cell O +
bank O +
. O +

( O +
F O +
) O +
Bisulfite O +
sequencing O +
analysis O +
of O +
the O +
8 O +
genes O +
in O +
endometrial O +
cells O +
( O +
UtE1104 B-CellLine +
) O +
, O +
UtE B-CellLine +
- I-CellLine +
iPS I-CellLine +
- I-CellLine +
11 I-CellLine +
and O +
HUES B-CellLine +
- I-CellLine +
8 I-CellLine +
cells O +
. O +

A O +
well O +
- O +
defined O +
panel O +
of O +
cisplatin O +
- O +
sensitive O +
and O +
resistant O +
EC O +
cell O +
lines O +
833KE B-CellLine +
, O +
Tera B-CellLine +
, O +
Tera B-CellLine +
- I-CellLine +
CP I-CellLine +
, O +
Scha B-CellLine +
, O +
and O +
2102EP B-CellLine +
( O +
all O +
expressing O +
wild O +
- O +
type O +
p53 O +
) O +
and O +
NCCIT B-CellLine +
( O +
mutant O +
p53 O +
) O +
were O +
used O +
in O +
this O +
study O +
. O +
3 O +
, O +
19 O +
, O +
30 O +
, O +
38 O +
, O +
39 O +
Tera B-CellLine +
, O +
Tera B-CellLine +
- I-CellLine +
CP I-CellLine +
, O +
2102EP B-CellLine +
, O +
Scha B-CellLine +
, O +
833KE B-CellLine +
, O +
and O +
NCCIT B-CellLine +
were O +
cultured O +
and O +
harvested O +
as O +
described O +
previously O +
. O +
19 O +
The O +
cell O +
lines O +
OCI B-CellLine +
- I-CellLine +
AML I-CellLine +
- I-CellLine +
3 I-CellLine +
, O +
MOLM B-CellLine +
- I-CellLine +
13 I-CellLine +
, O +
HL B-CellLine +
- I-CellLine +
60 I-CellLine +
, O +
KM B-CellLine +
- I-CellLine +
H2 I-CellLine +
, O +
L540 B-CellLine +
, O +
and O +
L428 B-CellLine +
were O +
maintained O +
as O +
described O +
previously O +
. O +
21 O +
, O +
22 O +
Cisplatin O +
was O +
purchased O +
from O +
Bristol O +
- O +
Myers O +
Co O +
. O +

( O +
D O +
) O +
MiHA O +
mediated O +
cytotoxicity O +
on O +
the O +
HLA O +
- O +
B7 O +
+ O +
RCC O +
cell O +
lines O +
SKRC33 B-CellLine +
( O +
rs2074071 O +
genotype O +
AA O +
) O +
and O +
SKRC18 B-CellLine +
( O +
rs2074071 O +
genotype O +
GG O +
) O +
, O +
the O +
brain O +
tumor O +
cell O +
line O +
DAOY B-CellLine +
( O +
rs2074071 O +
genotype O +
AG O +
) O +
, O +
and O +
pharynx O +
cell O +
line O +
FaDu B-CellLine +
( O +
rs2074071 O +
genotype O +
GG O +
) O +
, O +
in O +
flow O +
cytometry O +
- O +
based O +
cytotoxicity O +
assays O +
was O +
determined O +
after O +
incubation O +
with O +
CTL O +
B1 O +
( O +
* O +
) O +
, O +
allo O +
- O +
HLA O +
- O +
B7 O +
CTL O +
( O +
; O +
positive O +
control O +
) O +
or O +
medium O +
only O +
( O +
* O +
) O +
at O +
an O +
E O +
: O +
T O +
ratio O +
of O +
3 O +
: O +
1 O +
in O +
the O +
presence O +
of O +
25 O +
U O +
/ O +
ml O +
IL O +
- O +
2 O +
. O +

Electroporation O +
of O +
SUDHL B-CellLine +
- I-CellLine +
2 I-CellLine +
and O +
LNCaP B-CellLine +
was O +
as O +
above O +
except O +
that O +
, O +
for O +
SUDHL B-CellLine +
- I-CellLine +
2 I-CellLine +
cells O +
, O +
program O +
O O +
- O +
17 O +
was O +
used O +
. O +

We O +
observed O +
that O +
LIM1899 B-CellLine +
cells O +
overexpressing O +
LGR5 O +
tend O +
to O +
grow O +
in O +
' O +
colonies O +
' O +
with O +
tight O +
cell O +
- O +
to O +
- O +
cell O +
contacts O +
, O +
while O +
LIM1215 B-CellLine +
and O +
LIM1899 B-CellLine +
cells O +
with O +
reduced O +
LGR5 O +
are O +
more O +
diffuse O +
on O +
the O +
plastic O +
surface O +
( O +
not O +
shown O +
) O +
. O +

SCC O +
lung O +
cancer O +
cell O +
lines O +
LK2 B-CellLine +
( O +
RIKEN O +
, O +
Japan O +
) O +
, O +
NCI B-CellLine +
- I-CellLine +
H520 I-CellLine +
( O +
ATCC O +
, O +
Monassas O +
, O +
VA O +
) O +
, O +
LUDLU B-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
ECACC O +
, O +
UK O +
) O +
and O +
HARA B-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
HSSRB O +
, O +
Japan O +
) O +
were O +
maintained O +
in O +
HyClone O +
RPMI O +
- O +
1640 O +
medium O +
supplemented O +
with O +
10 O +
% O +
FBS O +
( O +
Thermo O +
Fisher O +
Scientific O +
Inc O +
. O +
, O +
Waltham O +
, O +
MA O +
) O +
. O +

Similarly O +
, O +
xylanase O +
isolated O +
from O +
B O +
. O +
coagulans O +
BL69 O +
grown O +
on O +
soybean O +
residue O +
[ O +
29 O +
] O +
showed O +
an O +
optimum O +
pH O +
of O +
7 O +
. O +
0 O +
. O +

Subclones O +
of O +
the O +
mPitA B-CellLine +
- I-CellLine +
1 I-CellLine +
and O +
- B-CellLine +
3 I-CellLine +
lines O +
expressed O +
SOX2 O +
, O +
indicating O +
that O +
they O +
might O +
consist O +
of O +
undifferentiated O +
pituitary O +
gonadotrophs O +
[ O +
7 O +
] O +
, O +
[ O +
8 O +
] O +
. O +

These O +
results O +
demonstrate O +
that O +
HIV O +
- O +
1 O +
replication O +
is O +
Nef O +
- O +
dependent O +
in O +
both O +
the O +
U87MG B-CellLine +
- O +
CD4 O +
+ O +
/ O +
CXCR4 O +
+ O +
and O +
CEM B-CellLine +
T4 I-CellLine +
cell O +
lines O +
, O +
providing O +
an O +
important O +
new O +
tool O +
to O +
assess O +
the O +
broad O +
efficacy O +
of O +
small O +
molecule O +
inhibitors O +
of O +
Nef O +
function O +
on O +
M O +
- O +
group O +
HIV O +
- O +
1 O +
replication O +
. O +

TOK O +
assisted O +
in O +
assessing O +
pathological O +
severity O +
, O +
experimental O +
design O +
and O +
manuscript O +
editing O +
. O +

In O +
the O +
deposited O +
ECM O +
, O +
the O +
190 O +
- O +
kDa O +
precursor O +
alpha3 O +
chain O +
, O +
which O +
contains O +
the O +
LG4 O +
- O +
5 O +
domain O +
, O +
was O +
detected O +
only O +
in O +
the O +
cultures O +
of O +
NHK O +
and O +
STKM B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
. O +

Youm O +
et O +
al O +
. O +
[ O +
35 O +
] O +
observed O +
that O +
the O +
bioactivity O +
against O +
SUM B-CellLine +
225 I-CellLine +
cells O +
was O +
higher O +
for O +
free O +
versus O +
encapsulated O +
docetaxel O +
at O +
lower O +
concentrations O +
( O +
2 O +
. O +
5 O +
muM O +
) O +
, O +
but O +
was O +
significantly O +
higher O +
for O +
the O +
encapsulated O +
form O +
at O +
the O +
highest O +
concentration O +
( O +
5 O +
muM O +
) O +
. O +

However O +
, O +
many O +
SETDB1 O +
target O +
genes O +
in O +
both O +
WM451Lu B-CellLine +
and O +
WM262 B-CellLine +
lines O +
are O +
not O +
methylated O +
, O +
and O +
additional O +
analyses O +
show O +
a O +
relationship O +
between O +
higher O +
SETDB1 O +
levels O +
and O +
elevated O +
expression O +
of O +
many O +
SETDB1 O +
targets O +
( O +
Supplementary O +
Fig O +
. O +
14 O +
) O +
. O +

Increased O +
sensitivity O +
of O +
the O +
LCMV O +
- O +
NP O +
FACS O +
assay O +
: O +
practical O +
application O +
to O +
in O +
vivo O +
models O +
of O +
LCMV O +
cl13 O +
and O +
LCMV O +
Arm O +
infection O +

Thereby O +
absorption O +
at O +
450 O +
nm O +
( O +
OD450 O +
nm O +
) O +
values O +
of O +
the O +
positive O +
control O +
, O +
namely O +
Vero B-CellLine +
B4 I-CellLine +
cells O +
infected O +
with O +
VEEV O +
, O +
were O +
set O +
as O +
100 O +
% O +
infectivity O +
. O +

OCI B-CellLine +
- I-CellLine +
Ly1 I-CellLine +
and O +
OCI B-CellLine +
- I-CellLine +
Ly3 I-CellLine +
were O +
maintained O +
in O +
Iscove O +
' O +
s O +
modified O +
essential O +
medium O +
with O +
beta O +
- O +
mercaptoethanol O +
( O +
55 O +
muM O +
) O +
, O +
penicillin O +
( O +
50 O +
units O +
/ O +
ml O +
) O +
, O +
streptomycin O +
( O +
50 O +
mug O +
/ O +
ml O +
) O +
, O +
and O +
20 O +
% O +
heparinized O +
normal O +
human O +
plasma O +
. O +

In O +
assessing O +
function O +
, O +
HIV O +
- O +
1 O +
tat O +
- O +
mediated O +
transactivation O +
was O +
measured O +
using O +
H938 B-CellLine +
cells O +
, O +
a O +
cell O +
line O +
that O +
contains O +
the O +
HIV O +
- O +
LTR O +
( O +
long O +
terminal O +
repeat O +
) O +
promoter O +
linked O +
to O +
a O +
chloramphenicol O +
acetyltransferase O +
gene O +
. O +

Exclusively O +
the O +
incubation O +
of O +
DH82 B-CellLine +
cell O +
pellets O +
with O +
mAbs O +
from O +
clone O +
2D10 B-CellLine +
resulted O +
in O +
a O +
cell O +
membrane O +
associated O +
immunoreaction O +
. O +

In O +
the O +
present O +
study O +
, O +
the O +
effects O +
of O +
some O +
selected O +
flavonoids O +
, O +
genistein O +
, O +
apigenin O +
, O +
luteolin O +
, O +
chrysin O +
, O +
kaempferol O +
, O +
and O +
biochanin O +
A O +
on O +
human O +
thyroid O +
carcinoma O +
cell O +
lines O +
, O +
UCLA B-CellLine +
NPA I-CellLine +
- I-CellLine +
87 I-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
NPA B-CellLine +
) O +
( O +
papillary O +
carcinoma O +
) O +
, O +
UCLA B-CellLine +
RO I-CellLine +
- I-CellLine +
82W I-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
WRO B-CellLine +
) O +
( O +
follicular O +
carcinoma O +
) O +
, O +
and O +
UCLA B-CellLine +
RO I-CellLine +
- I-CellLine +
81A I-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
ARO B-CellLine +
) O +
( O +
anaplastic O +
carcinoma O +
) O +
have O +
been O +
examined O +
. O +

Test O +
system O +
based O +
on O +
recombinant O +
polypeptides O +
HE40 O +
and O +
HE60 O +
was O +
used O +
for O +
deciphering O +
the O +
etiological O +
structure O +
of O +
acute O +
viral O +
hepatitis O +
which O +
occurred O +
in O +
a O +
hepatitis O +
E O +
endemic O +
region O +
of O +
Uzbekistan O +
in O +
1993 O +
. O +

Here O +
, O +
we O +
developed O +
the O +
6F10 O +
mAb O +
, O +
which O +
recognizes O +
a O +
cell O +
surface O +
glycoprotein O +
designated O +
lymphocyte O +
endothelial O +
- O +
epithelial O +
cell O +
adhesion O +
molecule O +
( O +
LEEP O +
- O +
CAM O +
) O +
, O +
that O +
is O +
distinct O +
in O +
biochemical O +
characteristics O +
and O +
distribution O +
of O +
expression O +
from O +
other O +
molecules O +
known O +
to O +
play O +
a O +
role O +
in O +
lymphocyte O +
adhesion O +
. O +

We O +
conclude O +
that O +
epinephrine O +
increases O +
ALC O +
by O +
stimulating O +
beta O +
- O +
adrenoceptors O +
and O +
sodium O +
transport O +
, O +
that O +
the O +
increase O +
is O +
reversible O +
once O +
plasma O +
epinephrine O +
concentration O +
normalizes O +
, O +
and O +
that O +
desensitization O +
of O +
the O +
ALC O +
response O +
does O +
not O +
appear O +
to O +
occur O +
after O +
4 O +
h O +
of O +
continuous O +
epinephrine O +
exposure O +
. O +

Peak O +
tumor O +
levels O +
of O +
released O +
dox O +
were O +
7 O +
- O +
fold O +
greater O +
in O +
the O +
responsive O +
MAC15A B-CellLine +
tumor O +
( O +
53 O +
microg O +
x O +
ml O +
( O +
- O +
1 O +
) O +
) O +
compared O +
with O +
the O +
less O +
responsive O +
MAC26 B-CellLine +
tumor O +
( O +
7 O +
. O +
7 O +
microg O +
x O +
ml O +
( O +
- O +
1 O +
) O +
) O +
and O +
more O +
than O +
18 O +
- O +
fold O +
greater O +
in O +
MAC15A B-CellLine +
than O +
when O +
free O +
dox O +
was O +
given O +
. O +

XP4PA B-CellLine +
- I-CellLine +
SV I-CellLine +
- I-CellLine +
EB I-CellLine +
cells O +
had O +
undetectable O +
XPC O +
mRNA O +
and O +
protein O +
levels O +
. O +

Transfection O +
of O +
LAN B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
with O +
rat O +
CD59 O +
, O +
an O +
inhibitor O +
of O +
the O +
terminal O +
cytolytic O +
membrane O +
attack O +
complex O +
, O +
effectively O +
protected O +
the O +
cells O +
from O +
lysis O +
by O +
rat O +
complement O +
in O +
vitro O +
. O +

The O +
cooperative O +
antitumor O +
effects O +
of O +
IL O +
- O +
12 O +
and O +
IL O +
- O +
15 O +
gene O +
transfer O +
were O +
studied O +
in O +
the O +
N592 B-CellLine +
MHC O +
class O +
I O +
- O +
negative O +
small O +
cell O +
lung O +
cancer O +
cell O +
line O +
xenotransplanted O +
in O +
nude O +
mice O +
. O +

RT O +
- O +
- O +
PCR O +
analysis O +
confirmed O +
the O +
presence O +
of O +
hY O +
( O +
4 O +
) O +
receptor O +
mRNA O +
in O +
Col B-CellLine +
- I-CellLine +
24 I-CellLine +
and O +
Col B-CellLine +
- I-CellLine +
1 I-CellLine +
epithelia O +
but O +
a O +
barely O +
visible O +
hY O +
( O +
4 O +
) O +
product O +
was O +
observed O +
in O +
Col B-CellLine +
- I-CellLine +
6 I-CellLine +
and O +
we O +
suggest O +
that O +
an O +
atypical O +
Y O +
( O +
4 O +
) O +
receptor O +
is O +
expressed O +
in O +
this O +
cell O +
line O +
. O +

IL O +
- O +
1alpha O +
had O +
no O +
influence O +
on O +
collagen O +
synthesis O +
but O +
increased O +
the O +
number O +
of O +
WI B-CellLine +
- I-CellLine +
1003 I-CellLine +
fibroblasts O +
. O +

Human O +
monoblastic O +
Mono B-CellLine +
- I-CellLine +
Mac I-CellLine +
- I-CellLine +
6 I-CellLine +
cells O +
produced O +
up O +
to O +
threefold O +
- O +
greater O +
levels O +
of O +
TNF O +
- O +
alpha O +
when O +
simultaneously O +
stimulated O +
with O +
LPS O +
and O +
IFN O +
- O +
gamma O +
compared O +
to O +
treatment O +
with O +
LPS O +
alone O +
. O +

RESULTS O +
: O +
HFL B-CellLine +
- I-CellLine +
1 I-CellLine +
and O +
BEAS B-CellLine +
- I-CellLine +
2B I-CellLine +
cells O +
released O +
ECA O +
in O +
a O +
dose O +
and O +
time O +
dependent O +
manner O +
in O +
response O +
to O +
MTX O +
. O +

PURPOSE O +
: O +
The O +
effect O +
of O +
genistein O +
, O +
a O +
tyrosine O +
kinase O +
inhibitor O +
, O +
on O +
radiosensitivity O +
was O +
examined O +
, O +
especially O +
focusing O +
on O +
" O +
survival O +
signal O +
transduction O +
pathways O +
. O +
" O +
METHODS O +
AND O +
MATERIALS O +
: O +
Two O +
human O +
esophageal O +
squamous O +
cell O +
cancer O +
cell O +
lines O +
, O +
TE B-CellLine +
- I-CellLine +
1 I-CellLine +
( O +
p53 O +
, O +
mutant O +
) O +
and O +
TE B-CellLine +
- I-CellLine +
2 I-CellLine +
( O +
p53 O +
, O +
wild O +
) O +
, O +
were O +
used O +
. O +

Treatment O +
of O +
MDA B-CellLine +
- I-CellLine +
453 I-CellLine +
tumor O +
cells O +
, O +
which O +
are O +
mitogenically O +
driven O +
through O +
erbB O +
- O +
2 O +
tyrosine O +
kinase O +
- O +
dependent O +
pathways O +
, O +
with O +
Pmp O +
- O +
containing O +
inhibitors O +
resulted O +
in O +
growth O +
inhibition O +
, O +
with O +
the O +
N O +
( O +
alpha O +
) O +
- O +
oxalyl O +
and O +
N O +
( O +
alpha O +
) O +
- O +
malonyl O +
- O +
containing O +
compounds O +
exhibiting O +
IC O +
( O +
50 O +
) O +
values O +
( O +
4 O +
. O +
3 O +
and O +
4 O +
. O +
6 O +
microM O +
, O +
respectively O +
) O +
approximately O +
five O +
- O +
fold O +
lower O +
than O +
the O +
parent O +
N O +
( O +
alpha O +
) O +
- O +
acetyl O +
- O +
containing O +
compound O +
. O +

It O +
also O +
rendered O +
SKN B-CellLine +
- I-CellLine +
SH I-CellLine +
cells O +
resistant O +
to O +
doxorubicin O +
as O +
demonstrated O +
by O +
a O +
sharp O +
decrease O +
in O +
doxorubicin O +
- O +
induced O +
DNA O +
degradation O +
and O +
cytotoxic O +
potency O +
. O +

The O +
cell O +
lines O +
Daoy B-CellLine +
and O +
MHH B-CellLine +
- I-CellLine +
PNET I-CellLine +
- I-CellLine +
5 I-CellLine +
in O +
which O +
the O +
p16 O +
( O +
INK4A O +
) O +
promoter O +
was O +
methylated O +
did O +
not O +
express O +
the O +
gene O +
, O +
but O +
demonstrated O +
abnormalities O +
by O +
SSCP O +
. O +

RT O +
- O +
PCR O +
and O +
ELISA O +
demonstrated O +
that O +
the O +
major O +
factors O +
responsible O +
for O +
LPL O +
inhibition O +
and O +
lipolysis O +
were O +
not O +
IL O +
- O +
1beta O +
, O +
IL O +
- O +
6 O +
, O +
IL O +
- O +
11 O +
, O +
TNF O +
- O +
alpha O +
, O +
TGF O +
- O +
beta1 O +
or O +
LIF O +
in O +
all O +
the O +
cancer O +
cell O +
lines O +
except O +
for O +
MMG B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
. O +

For O +
uroguanylin O +
two O +
distinct O +
signaling O +
pathways O +
exist O +
in O +
IHKE B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
, O +
one O +
involves O +
GC O +
- O +
C O +
and O +
cGMP O +
as O +
second O +
messenger O +
, O +
the O +
other O +
is O +
cGMP O +
- O +
independent O +
and O +
connected O +
to O +
a O +
pertussis O +
toxin O +
- O +
sensitive O +
G O +
protein O +
. O +

Cultured O +
cells O +
from O +
Morris B-CellLine +
hepatoma I-CellLine +
7316A I-CellLine +
contained O +
isozymes O +
I O +
and O +
II O +
, O +
but O +
not O +
isozyme O +
III O +
, O +
of O +
branched O +
- O +
chain O +
amino O +
acid O +
transaminase O +
. O +

The O +
increment O +
in O +
IL O +
- O +
5 O +
suggests O +
that O +
FLO O +
may O +
preferentially O +
stimulate O +
immunoglobulin O +
A O +
. O +

Ad5WS1 O +
caused O +
more O +
severe O +
cytolytic O +
effect O +
and O +
replicated O +
more O +
efficiently O +
in O +
J82 B-CellLine +
and O +
TCC B-CellLine +
- I-CellLine +
SUP I-CellLine +
bladder O +
cancer O +
cells O +
carrying O +
mutant O +
p53 O +
compared O +
with O +
TSGH B-CellLine +
- I-CellLine +
8301 I-CellLine +
and O +
BFTC B-CellLine +
- I-CellLine +
905 I-CellLine +
bladder O +
cancer O +
cells O +
retaining O +
wild O +
- O +
type O +
p53 O +
. O +

Flow O +
cytometric O +
analysis O +
of O +
the O +
expression O +
of O +
TAA O +
with O +
monoclonal O +
antibody O +
( O +
mAb O +
) O +
c143 O +
showed O +
high O +
expression O +
of O +
TAA O +
on O +
the O +
surfaces O +
of O +
BL2M3 B-CellLine +
and O +
BL312 B-CellLine +
cells O +
. O +

The O +
cell O +
lines O +
were O +
named O +
NUTLC B-CellLine +
- I-CellLine +
2 I-CellLine +
, O +
NUTLC B-CellLine +
- I-CellLine +
4 I-CellLine +
and O +
NUTLC B-CellLine +
- I-CellLine +
5 I-CellLine +
and O +
they O +
were O +
found O +
to O +
have O +
the O +
following O +
biological O +
characterization O +
. O +

IL O +
- O +
3 O +
and O +
IL O +
- O +
6 O +
stimulated O +
cell O +
proliferation O +
but O +
had O +
no O +
effect O +
on O +
cell O +
differentiation O +
, O +
whereas O +
IL O +
- O +
1 O +
and O +
G O +
- O +
CSF O +
affected O +
neither O +
differentiation O +
nor O +
proliferation O +
of O +
Eos B-CellLine +
- I-CellLine +
HL I-CellLine +
- I-CellLine +
60 I-CellLine +
cells O +
under O +
the O +
conditions O +
tested O +
. O +

Cytotoxicity O +
of O +
GSH O +
depletion O +
by O +
buthionine O +
sulfoximine O +
in O +
CHLA B-CellLine +
- I-CellLine +
20 I-CellLine +
( O +
but O +
not O +
in O +
CHLA B-CellLine +
- I-CellLine +
20 I-CellLine +
- I-CellLine +
eGFP I-CellLine +
) O +
was O +
diminished O +
by O +
hypoxia O +
( O +
2 O +
% O +
O O +
( O +
2 O +
) O +
) O +
. O +

The O +
lowest O +
and O +
highest O +
EPP O +
amplitudes O +
are O +
designated O +
" O +
small O +
- O +
EPP O +
" O +
and O +
" O +
large O +
- O +
EPP O +
, O +
" O +
respectively O +
. O +
In O +
singly O +
innervated O +
endplates O +
and O +
large O +
- O +
EPP O +
, O +
we O +
found O +
an O +
inhibition O +
of O +
acetylcholine O +
release O +
by O +
M1 O +
- O +
receptor O +
antagonists O +
pirenzepine O +
and O +
MT O +
- O +
7 O +
( O +
more O +
than O +
30 O +
% O +
) O +
and O +
M2 O +
- O +
receptor O +
antagonists O +
methoctramine O +
and O +
AF O +
- O +
DX O +
116 O +
( O +
more O +
than O +
40 O +
% O +
) O +
. O +

All O +
the O +
melanoma O +
cells O +
expressed O +
ATX O +
, O +
and O +
except O +
for O +
the O +
HTB B-CellLine +
- I-CellLine +
72 I-CellLine +
and O +
normal O +
cells O +
, O +
all O +
secreted O +
ATX O +
. O +

Comparative O +
studies O +
of O +
a O +
92 O +
- O +
kDa O +
gelatinolytic O +
metalloproteinase O +
from O +
U937 B-CellLine +
cells O +
and O +
matrix O +
metalloproteinase O +
2 O +
from O +
human O +
rheumatoid O +
synovial O +
fibroblasts O +
. O +

Its O +
ligands O +
, O +
CCL O +
- O +
19 O +
( O +
MIP O +
- O +
3beta O +
) O +
and O +
CCL O +
- O +
21 O +
( O +
SLC O +
) O +
, O +
play O +
an O +
important O +
role O +
in O +
the O +
migration O +
of O +
these O +
cells O +
to O +
secondary O +
lymphoid O +
organs O +
where O +
they O +
are O +
predominantly O +
expressed O +
. O +

PEG O +
- O +
rHuMGDF O +
administration O +
prolonged O +
survival O +
of O +
L B-CellLine +
- I-CellLine +
8057 I-CellLine +
leukemic O +
mice O +
, O +
in O +
which O +
L B-CellLine +
- I-CellLine +
8057 I-CellLine +
cell O +
growth O +
in O +
the O +
spleen O +
was O +
decreased O +
. O +

. O +
The O +
biological O +
activities O +
of O +
the O +
wild O +
type O +
and O +
mutant O +
proteins O +
were O +
studied O +
using O +
E O +
. O +
coli O +
MB08 O +
( O +
selD O +
- O +
) O +
transformed O +
with O +
plasmids O +
containing O +
the O +
selD O +
gene O +

SP2 O +
exhibited O +
extracellular O +
virucidal O +
activity O +
only O +
in O +
high O +
concentrations O +
( O +
> O +
/ O +
= O +
12 O +
. O +
5 O +
microg O +
/ O +
ml O +
) O +
but O +
significantly O +
inhibited O +
the O +
virus O +
attachment O +
to O +
its O +
host O +
cells O +
by O +
45 O +
. O +
1 O +
% O +
, O +
at O +
concentration O +
as O +
low O +
as O +
1 O +
microg O +
/ O +
ml O +
. O +

The O +
results O +
demonstrated O +
that O +
, O +
with O +
the O +
exception O +
of O +
ET O +
- O +
1 O +
( O +
biphasic O +
effect O +
) O +
and O +
ET O +
- O +
3 O +
( O +
no O +
significant O +
effect O +
) O +
in O +
undifferentiated O +
GEM B-CellLine +
- I-CellLine +
81 I-CellLine +
cells O +
, O +
all O +
the O +
tested O +
hormones O +
induced O +
increases O +
in O +
the O +
proliferation O +
of O +
both O +
types O +
of O +
cells O +
. O +

Various O +
combinations O +
of O +
retinoids O +
and O +
cytokines O +
were O +
examined O +
for O +
their O +
synergistic O +
effect O +
on O +
inhibition O +
in O +
proliferation O +
of O +
four O +
human O +
transformed O +
epithelial O +
cell O +
lines O +
, O +
MCF7 B-CellLine +
( O +
mammary O +
carcinoma O +
) O +
, O +
SCC4 B-CellLine +
, O +
SCC15 B-CellLine +
and O +
A431 B-CellLine +
( O +
squamous O +
cell O +
carcinomas O +
) O +
. O +

Deuterium O +
studies O +
indicate O +
that O +
water O +
is O +
the O +
source O +
of O +
hydrogen O +
in O +
the O +
C8 O +
- O +
H O +
product O +
and O +
not O +
the O +
alkylthio O +
group O +
, O +
suggesting O +
that O +
reversion O +
of O +
( O +
1 O +
) O +
to O +
adenosine O +
is O +
not O +
a O +
consequence O +
of O +
simple O +
homolysis O +
of O +
the O +
C8 O +
- O +
S O +
bond O +
but O +
of O +
an O +
unprecedented O +
photochemical O +
conversion O +
. O +

More O +
importantly O +
, O +
G O +
- O +
120 O +
strongly O +
reduced O +
the O +
gelatinolytic O +
and O +
collagenase O +
activities O +
of O +
MMP O +
proteins O +
, O +
as O +
well O +
as O +
expression O +
of O +
MMP O +
- O +
2 O +
and O +
MMP O +
- O +
9 O +
. O +

The O +
frequency O +
of O +
end O +
- O +
to O +
- O +
end O +
chromosome O +
fusions O +
did O +
not O +
change O +
after O +
exposure O +
of O +
GM14090 B-CellLine +
cells O +
to O +
bleomycin O +
but O +
we O +
observed O +
elevated O +
levels O +
of O +
chromosomal O +
abnormalities O +
involving O +
interactions O +
between O +
DNA O +
double O +
strand O +
breaks O +
and O +
uncapped O +
telomeres O +
in O +
this O +
cell O +
line O +
. O +

T O +
- O +
bet O +
was O +
clearly O +
induced O +
in O +
the O +
two O +
cell O +
lines O +
NALM B-CellLine +
- I-CellLine +
19 I-CellLine +
and O +
NALM B-CellLine +
- I-CellLine +
29 I-CellLine +
after O +
stimulation O +
. O +

RESULTS O +
: O +
Of O +
the O +
cell O +
lines O +
tested O +
, O +
EDG O +
- O +
7 O +
mRNA O +
was O +
expressed O +
most O +
intensely O +
in O +
CRL B-CellLine +
- I-CellLine +
11731 I-CellLine +
and O +
CRL B-CellLine +
- I-CellLine +
1572 I-CellLine +
and O +
at O +
a O +
lesser O +
but O +
still O +
substantial O +
level O +
in O +
CRL B-CellLine +
- I-CellLine +
11732 I-CellLine +
. O +

Pretreatment O +
of O +
FDCP B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
with O +
chondroitinase O +
ABC O +
, O +
which O +
selectively O +
removes O +
the O +
CS O +
portion O +
of O +
the O +
MA O +
- O +
PG O +
, O +
also O +
affects O +
binding O +
to O +
the O +
stromal O +
cells O +
. O +

To O +
confirm O +
these O +
findings O +
, O +
similar O +
studies O +
were O +
conducted O +
in O +
two O +
pairs O +
of O +
transfectant O +
sublines O +
established O +
from O +
the O +
Ku86 O +
- O +
deficient O +
Chinese O +
hamster O +
lung O +
fibroblast O +
XR B-CellLine +
- I-CellLine +
V15B I-CellLine +
cells O +
. O +

MATERIALS O +
AND O +
METHODS O +
: O +
The O +
LNCaP B-CellLine +
FGC I-CellLine +
prostate O +
cancer O +
cell O +
line O +
was O +
grown O +
in O +
vitro O +
within O +
a O +
three O +
- O +
dimensional O +
matrix O +
formed O +
by O +
collagen O +
gel O +
under O +
dihydrotestosterone O +
( O +
DHT O +
) O +
( O +
0 O +
. O +
1 O +
nM O +
) O +
stimulation O +
. O +

Peripheral O +
blood O +
mononuclear O +
cells O +
of O +
an O +
immunized O +
patient O +
were O +
transformed O +
with O +
Epstein O +
- O +
Barr O +
virus O +
and O +
then O +
fused O +
with O +
P3X63Ag8 B-CellLine +
mouse O +
myeloma O +
cells O +
by O +
polyethylene O +
glycol O +
. O +

However O +
, O +
only O +
the O +
ECE O +
- O +
1c O +
protein O +
was O +
detectable O +
in O +
PC B-CellLine +
- I-CellLine +
3 I-CellLine +
, O +
Du145 B-CellLine +
, O +
PNT2 B-CellLine +
- I-CellLine +
C2 I-CellLine +
, O +
and O +
PNT1 B-CellLine +
- I-CellLine +
a I-CellLine +
cells O +
. O +

Potent O +
antiproliferative O +
effects O +
of O +
resveratrol O +
on O +
human O +
osteosarcoma O +
SJSA1 B-CellLine +
cells O +
: O +
Novel O +
cellular O +
mechanisms O +
involving O +
the O +
ERKs O +
/ O +
p53 O +
cascade O +
. O +

Only O +
1 O +
/ O +
10 O +
long O +
- O +
term O +
non O +
- O +
progressors O +
( O +
LTNPs O +
) O +
had O +
an O +
MBL O +
- O +
2 O +
mutation O +
( O +
A O +
/ O +
D O +
) O +
with O +
a O +
corresponding O +
protein O +
level O +
of O +
611 O +
ng O +
/ O +
ml O +
. O +

Our O +
preliminary O +
assay O +
demonstrated O +
that O +
JB6 B-CellLine +
Cl41 I-CellLine +
cells O +
with O +
the O +
treatment O +
of O +
HA O +
at O +
the O +
concentration O +
of O +
100 O +
microg O +
/ O +
ml O +
for O +
72 O +
and O +
96 O +
h O +
significantly O +
increased O +
reactive O +
oxygen O +
species O +
( O +
ROS O +
) O +
as O +
compared O +
to O +
the O +
untreated O +
control O +
. O +

Optimization O +
, O +
focusing O +
on O +
activity O +
and O +
lipophilicity O +
needed O +
for O +
cell O +
permeability O +
, O +
resulted O +
in O +
the O +
identification O +
of O +
15b O +
and O +
15e O +
with O +
good O +
activity O +
( O +
IC50 O +
= O +
1 O +
. O +
6 O +
nM O +
each O +
) O +
and O +
moderate O +
lipophilicity O +
( O +
Log O +
D O +
= O +
2 O +
. O +
0 O +
, O +
1 O +
. O +
8 O +
) O +
. O +

CONCLUSION O +
: O +
FPS B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
might O +
be O +
useful O +
for O +
investigating O +
biological O +
behavior O +
and O +
developing O +
new O +
molecular O +
targeting O +
antitumor O +
drugs O +
for O +
UPS O +
with O +
EGFR O +
or O +
COX O +
- O +
2 O +
expression O +
. O +

Studies O +
on O +
endogenous O +
Spred O +
- O +
2 O +
in O +
ME4405 B-CellLine +
melanoma O +
cells O +
showed O +
that O +
pervanadate O +
induced O +
Spred O +
- O +
2 O +
ubiquitination O +
and O +
a O +
marked O +
reduction O +
in O +
Spred O +
- O +
2 O +
steady O +
- O +
state O +
levels O +
that O +
was O +
partially O +
blocked O +
by O +
the O +
proteasomal O +
inhibitor O +
, O +
MG O +
- O +
132 O +
. O +

Karyotype O +
was O +
normal O +
for O +
VAL B-CellLine +
- I-CellLine +
3 I-CellLine +
( O +
46XY O +
) O +
, O +
VAL B-CellLine +
- I-CellLine +
4 I-CellLine +
( O +
46XX O +
) O +
and O +
VAL B-CellLine +
- I-CellLine +
5 I-CellLine +
( O +
46XX O +
) O +
. O +

Our O +
previous O +
microarray O +
analysis O +
showed O +
that O +
N O +
- O +
methyl O +
- O +
N O +
- O +
nitrosourea O +
( O +
MNU O +
) O +
transformed O +
MCF12F B-CellLine +
breast O +
epithelial O +
cells O +
exhibited O +
upregulation O +
of O +
several O +
genes O +
, O +
including O +
prohibitin O +
, O +
which O +
was O +
reversed O +
by O +
1alpha O +
- O +
hydroxyvitamin O +
D O +
( O +
5 O +
) O +
( O +
1alpha O +
( O +
OH O +
) O +
D O +
( O +
5 O +
) O +
) O +
treatment O +
. O +

Laminin O +
- O +
5 O +
- O +
dependent O +
Met O +
activation O +
was O +
minimal O +
in O +
HCV29 B-CellLine +
cells O +
. O +

Additions O +
also O +
increase O +
the O +
highest O +
occupied O +
molecular O +
orbit O +
- O +
lowest O +
unoccupied O +
molecular O +
orbital O +
( O +
HOMO O +
- O +
LUMO O +
) O +
gaps O +
of O +
C50 O +
fullerides O +
and O +
make O +
them O +
chemically O +
more O +
stable O +
. O +

In O +
this O +
report O +
we O +
performed O +
in O +
vivo O +
dimethylsulfate O +
, O +
UV O +
type O +
C O +
irradiation O +
and O +
DNaseI O +
footprinting O +
analyses O +
coupled O +
with O +
ligation O +
- O +
mediated O +
PCR O +
on O +
nearly O +
1000 O +
bp O +
of O +
promoter O +
in O +
two O +
neuroblastoma O +
cell O +
lines O +
, O +
SJNB B-CellLine +
- I-CellLine +
7 I-CellLine +
( O +
expressing O +
GPC3 O +
) O +
and O +
SK B-CellLine +
- I-CellLine +
N I-CellLine +
- I-CellLine +
FI I-CellLine +
( O +
not O +
expressing O +
GPC3 O +
) O +
. O +

Following O +
stimulation O +
of O +
NRK49F B-CellLine +
rat O +
kidney O +
fibroblast O +
cells O +
with O +
epidermal O +
growth O +
factor O +
, O +
possible O +
preemptive O +
cross O +
- O +
talk O +
between O +
arginine O +
methylation O +
and O +
serine O +
and O +
tyrosine O +
phosphorylation O +
was O +
observed O +
for O +
Rho O +
guanidine O +
nucleotide O +
dissociation O +
inhibitor O +
1 O +
( O +
RhoGDI O +
- O +
1 O +
) O +
. O +

The O +
antiangiogenic O +
and O +
antineoplastic O +
activities O +
of O +
the O +
butyric O +
acid O +
prodrugs O +
AN O +
- O +
7 O +
and O +
AN O +
- O +
9 O +
were O +
demonstrated O +
in O +
vitro O +
with O +
HUVEC B-CellLine +
by O +
inhibition O +
of O +
proliferation O +
and O +
vascular O +
tubes O +
formation O +
, O +
enhanced O +
apoptosis O +
, O +
and O +
inhibition O +
of O +
22Rv B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
migration O +
. O +

AIs O +
for O +
the O +
LD O +
- O +
3 O +
groups O +
were O +
significantly O +
lower O +
compared O +
to O +
the O +
HD O +
- O +
3 O +
groups O +
( O +
p O +
< O +
0 O +
. O +
001 O +
) O +
, O +
but O +
all O +
AIs O +
were O +
significantly O +
increased O +
compared O +
to O +
C O +
groups O +
( O +
p O +
< O +
0 O +
. O +
01 O +
) O +
. O +

Conclusions O +
: O +
Our O +
findings O +
indicate O +
that O +
ACE O +
- O +
1 O +
activity O +
is O +
increased O +
in O +
AD O +
, O +
in O +
direct O +
relationship O +
to O +
parenchymal O +
Abeta O +
load O +
. O +

Targeted O +
inhibition O +
of O +
SET O +
- O +
NUP214 O +
by O +
siRNA O +
abolished O +
expression O +
of O +
HOXA O +
genes O +
, O +
inhibited O +
proliferation O +
, O +
and O +
induced O +
differentiation O +
in O +
LOUCY B-CellLine +
but O +
not O +
in O +
other O +
T O +
- O +
ALL O +
lines O +
. O +

Inoculation O +
of O +
SSN B-CellLine +
- I-CellLine +
1 I-CellLine +
and O +
SAF B-CellLine +
- I-CellLine +
1 I-CellLine +
cells O +
with O +
fish O +
samples O +
did O +
not O +
cause O +
cytopathic O +
effect O +
, O +
although O +
virus O +
was O +
detected O +
by O +
reverse O +
transcription O +
polymerase O +
chain O +
reaction O +
in O +
approximately O +
25 O +
% O +
of O +
the O +
SSN B-CellLine +
- I-CellLine +
1 I-CellLine +
inoculated O +
wells O +
. O +

Human O +
pancreatic O +
duct O +
epithelial O +
cell O +
model O +
for O +
KRAS O +
transformation O +
. O +

High O +
vimentin O +
expression O +
was O +
detected O +
in O +
1E8 B-CellLine +
- I-CellLine +
H I-CellLine +
compared O +
to O +
2B4 B-CellLine +
- I-CellLine +
L I-CellLine +
cells O +
. O +

The O +
BFTC B-CellLine +
- I-CellLine +
905 I-CellLine +
- I-CellLine +
diffuse I-CellLine +
M O +
cell O +
line O +
displayed O +
a O +
dramatic O +
increase O +
in O +
the O +
overall O +
chromosome O +
number O +
, O +
resulting O +
in O +
a O +
hypertetraploid O +
karyotype O +
. O +

The O +
phenoxazone O +
chromophore O +
of O +
Act O +
intercalates O +
at O +
the O +
( O +
G O +
- O +
C O +
) O +
I O +
. O +
( O +
G O +
- O +
C O +
) O +
II O +
step O +
in O +
the O +
d O +
( O +
A3GCT3 O +
) O +
duplex O +
with O +
the O +
phenoxazone O +
ring O +
stacking O +
selectively O +
with O +
the O +
G4I O +
and O +
G4II O +
purine O +
bases O +
but O +
not O +
with O +
C4I O +
and O +
C4II O +
pyrimidine O +
bases O +
at O +
the O +
intercalation O +
site O +
. O +

RESULTS O +
: O +
Substantial O +
variation O +
in O +
growth O +
and O +
in O +
the O +
ability O +
to O +
form O +
beating O +
areas O +
was O +
seen O +
between O +
the O +
different O +
hESC O +
lines O +
; O +
line O +
HS346 B-CellLine +
gave O +
the O +
best O +
efficiency O +
( O +
9 O +
. O +
4 O +
% O +
) O +
, O +
while O +
HS293 B-CellLine +
did O +
not O +
differentiate O +
into O +
beating O +
colonies O +
at O +
all O +
. O +

Rat O +
oral O +
glucose O +
tolerance O +
test O +
indicated O +
that O +
27e O +
exhibited O +
a O +
glucose O +
- O +
lowering O +
effect O +
after O +
10 O +
mg O +
/ O +
kg O +
oral O +
administration O +
. O +

Berberine O +
treatment O +
inhibited O +
cell O +
cancer O +
growth O +
in O +
a O +
concentration O +
( O +
0 O +
- O +
50 O +
microM O +
) O +
and O +
time O +
- O +
( O +
0 O +
- O +
48 O +
h O +
) O +
dependent O +
manner O +
without O +
any O +
growth O +
inhibition O +
in O +
normal O +
human O +
prostate O +
epithelial O +
PWR B-CellLine +
- I-CellLine +
1E I-CellLine +
cells O +
. O +

The O +
results O +
showed O +
that O +
in O +
the O +
13 O +
derivatives O +
, O +
the O +
hemolytic O +
toxicity O +
of O +
4 O +
- O +
methyl O +
PQ O +
derivatives O +
was O +
lower O +
than O +
that O +
of O +
PQ O +
while O +
5 O +
- O +
trifluoroacetyl O +
PQ O +
derivatives O +
exhibited O +
similar O +
hemolytic O +
potential O +
to O +
PQ O +
. O +

